Project Grant R35GM156451

Award Date 8/1/25
Completion Date 7/31/30
Dollars Obligated $275K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award, valued at $133,246, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding will support the development of flexible Bayesian statistical methods to gain a comprehensive understanding of microbial community dynamics using high-throughput sequencing data. The key objectives are to create a general method for inferring microbial community dynamics that vary with...
The National Institute of General Medical Sciences (NIGMS) awarded a $243,840 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The project, titled "An Effective Statistical Inference Framework to Develop Innovative Compensations for Protein Mutations," aims to develop quantitative methods for predicting the impact of protein mutations and identifying compensatory mutations that can restore normal protein...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $550,108 to the University of California, Merced to conduct research on the genetic regulation of microbial community formation, particularly in the context of biofilms. The research aims to enhance understanding of how transcriptional networks regulate gene expression during biofilm development, including in fungi,...
The National Institute of General Medical Sciences (NIGMS) has awarded a $492,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Princeton University. The grant, which runs from Sep 1, 2024 to Aug 31, 2029, supports research aimed at accessing previously hidden sources of microbial natural products and investigating their structures, functions, therapeutic uses, and biosynthetic pathways. Key objectives include eliciting cryptic metabolites from...
The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $401,248 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of California, Berkeley to develop new models and methods for understanding how demographic and social processes influence infectious disease risk. The project aims to create a generalized framework for jointly modeling human behavioral changes and disease dynamics, incorporating data on human mobility, aggregation, and other...
The National Institute of General Medical Sciences (NIGMS) awarded a $382,136 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Maryland, College Park. The five-year grant, effective May 1, 2025 through March 31, 2030, supports research to define engineering principles for designing programmable bioengineered multicellular structures (probioms) in prokaryotic cells. The goal is to develop these probioms, modeled after natural probiotic...
The National Institute of General Medical Sciences (NIGMS) awarded a $752,456 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The grant, effective September 1, 2024 through July 31, 2029, supports the development and application of innovative, user-friendly computational technologies for identifying new bioactive small molecules and improving their pharmacological properties. Key focus areas include creating a database of...
The National Institute of General Medical Sciences (NIGMS) awarded a $462,500 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to St. Jude Children's Research Hospital Inc. in Memphis, TN. The grant will support a 5-year research project to decipher the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics. The research aims to comprehensively characterize bacterial heterogeneity and identify genetic regulators...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $422,931 to characterize the role of specialized microbial metabolites in mediating interactions within the human microbiome. The award aims to integrate cheminformatics analysis of metabolomics data with in vitro model systems to elucidate novel chemistry that influences the structure and function of the microbiome, including...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $1,759,395.00 over 5 years to the University of Oregon to investigate the assembly, function, and health impacts of social microbiomes. The award supports a multidisciplinary research program that aims to establish a new field of study on how social interactions and associated microbial communities (social microbiomes) shape host health...

The National Institute of General Medical Sciences (NIGMS) awarded a $275,303 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The grant will fund a 5-year research project to develop predictive stochastic models that bridge the molecular, cellular, and population scales of microbial proliferation and population dynamics. Specifically, the research aims to: (i) understand the effects of molecular noise on microbial cell size control, (ii) model the effects of cell division noise on microbial population dynamics, and (iii) characterize the statistics of microbial population dynamics in fluctuating, clinically relevant environments. The project will leverage experimental collaborations to test the model predictions against new data from microfluidic culturing and DNA barcoding experiments. The outcome will be to transform the research group into leaders in theoretical multiscale population biology, with important implications for understanding the tumor microbiome and antibiotic resistance.

Generated 8/5/25, 4:23 AM